Here is the latest stock price and chart of Sun Pharma. For more details, see the Sun Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
India's Revival: A Once-in-a-Generation Wealth Making Opportunity
Live BSE Quotes | Apr 13, 2021 (Close) | ||
---|---|---|---|
Price (Rs)627.40 | Open (Rs) 620.55 | High (Rs) 635.30 | Low (Rs) 616.15 |
% Change1.33 | Volume 233,796 | Value (Rs) 146,063,336 | 52-Week H/L 653.70 / 434.25 |
Live NSE Quotes | Apr 13, 2021 (Close) | ||
---|---|---|---|
Price (Rs)627.35 | Open (Rs) 624.00 | High (Rs) 635.55 | Low (Rs) 616.10 |
% Change1.29 | Volume 7,399,207 | Value (Rs) 4,625,932,833 | 52-Week H/L 654.40 / 434.25 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.33% | 1 Month 3.64% | 3 Months 4.20% | 1 Year 35.77% | 5 Years (CAGR)* -5.48% | 10 Years (CAGR)* 10.87% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 8.02 | P/E Ratio (x) 78.20 | Market Cap (Rs m) 1,509,996.83 | P/BV (x) 3.34 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
SUN PHARMA last traded price was up 1.3% to Rs 627.4 on the BSE. On the NSE, SUN PHARMA last traded price was up 1.3% to Rs 627.4. The total volume of shares traded was 7.6 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.7%. And the benchmark S&P BSE SENSEX was at 48,544.1 (up 1.4%).
Over the last 30 days, the SUN PHARMA share price is up 2.3%. And over the last one year, SUN PHARMA share price is up 35.8%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.
For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
More Views on NewsA tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
What should you do if the market falls? In this video, I'll tell you what I will do.
Ajit Dayal on how India's vaccine strategy will impact the markets.
More